U.S. Withdraws from WHO: Impact on Global Health Security and Relations

By João L. Carapinha

January 21, 2025

President Trump has signed an executive order to begin the U.S. withdraws from WHO. The order cites the organization’s mishandling of the COVID-19 pandemic. It also highlights the WHO’s failure to implement necessary reforms and its lack of independence from political influence. Additionally, the order addresses the disproportionate financial contributions required from the U.S. compared to other countries. This move involves stopping U.S. funding and personnel support for the WHO. It also seeks alternative international partners.

The U.S. withdrawal from the WHO is driven by criticisms of its handling of the COVID-19 pandemic and other global health crises. The WHO faces accusations of failing to implement urgent reforms. It is also criticized for being unduly influenced by member states’ politics. The executive order emphasizes disparities in financial contributions. The U.S. contributes significantly more than countries like China, despite China’s larger population. The order revokes previous notifications and orders concerning U.S. involvement with the WHO. It directs government departments to stop funding and recall personnel while seeking new partners.

Background

The U.S. withdraws from WHO is not unprecedented. It was first initiated in 2020 but later retracted. The WHO has faced harsh criticism for its response to the COVID-19 pandemic, a major global health crisis. Health experts warn that this withdrawal could weaken global defenses against infectious diseases and pandemics. It may undo decades of progress in fighting diseases like AIDS, malaria, and tuberculosis.

The U.S. withdrawal from the WHO may compromise global health security. It could diminish U.S. influence and financial support essential for international health initiatives and pandemic preparedness. Stopping U.S. funding could severely affect the WHO’s ability to run global health programs. This might result in gaps in health services and research. The U.S. will need to forge new partnerships to continue supporting global health initiatives. This transition could create instability in global health governance. The withdrawal might also disrupt collaborative research efforts and the sharing of health data, which are critical for developing effective health policies.

Overall, the implications of the U.S. withdrawal from the WHO are extensive. They may have significant consequences for global health security, research, and outcomes.

Reference url

Recent Posts

Advancements in Immunotherapy for Hepatocellular Carcinoma: EMERALD-3 Trial Results

By João L. Carapinha

April 3, 2026

Immunotherapy hepatocellular carcinoma treatment has taken a significant step forward with positive high-level results from the EMERALD-3 Phase III trial. The addition of dual immunotherapy using AstraZeneca’s STRIDE regimen (Single Tremelimumab Regular Interval Durvalumab) together with lenvatin...
Facilitating Reimbursement for Intravesical Gemcitabine in Bladder Cancer Treatment
Reimbursement Bladder Cancer advances with the assignment of a permanent HCPCS J-code for INLEXZO™ (gemcitabine intravesical system), effective April 1, 2026. This standardized billing code simplifies reimbursement bladder cancer treatment for adult patients with BCG-unresponsive non-muscle invas...
100% Tariffs Impacting Pharmaceutical Manufacturing and National Security
President Donald J. Trump has imposed tariffs on patented pharmaceutical products and their ingredients, using tariffs pharmaceutical manufacturing policy to protect national security and strengthen U.S. supply chains. The move applies a baseline 100% tariff on patented pharmaceuticals, with lowe...